Results Demonstrate AT-587 To Be Highly Potent In Vitro Against Hepatitis E Virus Initiation of Phase 1 Clinical Program Anticipated ...
Results Demonstrate AT-587 To Be Highly Potent In Vitro Against Hepatitis E Virus Initiation of Phase 1 Clinical Program Anticipated Mid-2026 BOSTON, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Atea Pharmaceuti ...
Herpes simplex virus type 1 (HSV-1) infection dramatically remodels the host cell's nuclear structures. Infection leads to ...
Epstein–Barr virus infects most adults. Understanding its role in Multiple Sclerosis could transform prevention and treatment ...
Drugs made of mRNA have the potential to transform medicine—if only they could get into cells in one piece. Now, University ...
News-Medical.Net on MSN
Viral RNA modifications trigger celiac inflammation
An EHU study indicates that a drug already approved for use in humans could help to reduce the inflammation associated with celiac disease. The research, conducted by the FunImmune group, shows that ...
Viral infections remain a significant global health challenge, as exemplified by recent pandemics. The complexity of virus-host interplay poses major ...
News-Medical.Net on MSN
Single-cell RNA sequencing reveals accelerated T cell aging in viral infections
A new research paper was published in Volume 18 of Aging-US on February 8, 2026, titled "Single-cell transcriptomics reveal ...
5hon MSN
First cases of highly pathogenic avian influenza in northern elephant seals confirmed in California
Seven weaned elephant seal pups in California's Año Nuevo State Park tested positive for highly pathogenic avian influenza (HPAI) H5N1, the U.S. Department of Agriculture's National Veterinary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results